When I learned I had a stage 4 breast cancer, I decided not let it rob me of the opportunities to enjoy my life. I still have a physically active, socially engaged lifestyle, and if you have metastatic breast cancer, so can you. Read more
Oh yeah, isn’t that the first profile you would click on if you were searching for the love of your life or even just a new ‘friend’ online? Dating in itself – or, I should say, finding someone to date – is never easy. Finding someone when you happen to be bald, going through chemo and/or making daily trips to the hospital for radiation makes it a zillion times more complicated. I know. I’ve tried it.
A group of specialists at the National Cancer Institute recently issued a report calling for a redefinition of the word “cancer,” suggesting that it no longer be applied to certain premalignant and non-lethal conditions. Such a change, the panel wrote, may ease the fears of patients, making them less inclined to seek unnecessary and potentially harmful treatments. The findings reinforce earlier studies by physicians at Dana-Farbers’ Susan F. Smith Centers for Women’s Cancers and others.
An example of this kind of condition is ductal carcinoma in situ (DCIS), in which cancerous cells are confined to the milk ducts of the breast. It is the most common form of non-invasive breast cancer, found in more than 60,000 women in the U.S. each year, according to the American Cancer Society.Read more
After a long period of slow progress, new knowledge about the genetics of ovarian cancer is leading to the development and testing of new therapies.
Researchers at the Susan F. Smith Center for Women’s Cancers will soon be launching several phase 3 clinical trials testing drugs known as PARP inhibitors for patients with platinum-sensitive recurrent ovarian cancer – tumors that initially responded to platinum-based chemotherapy agents but have shown evidence of regrowth at least six months after treatment. Phase 3 trials test drugs in large numbers of patients to evaluate the drugs’ effectiveness as well as safety. PARP inhibitors work by blocking one of the pathways by which tumor cells repair their damaged DNA.
I can’t pinpoint when I started to get ovarian cancer symptoms. It was all very subtle and gradual. I was a healthy person. I ran, biked swam, hiked, and went to the gym regularly.
A slight pain in my left side, difficulty digesting food, feeling of fullness, and shortness of breath: those were the subtle constellation of symptoms that landed me in my primary care doctor’s office. At the age of 50, I felt like I was going downhill fast.
When you think of a cancer patient, you might envision someone frail and thin. But while weight loss can be a side effect, gaining weight during cancer treatment is also quite common. That’s why it’s important to find a healthy balance during treatment. Here are some tips. Read more
Actress Angelina Jolie is no stranger to the headlines, but she stunned the world with her Op-Ed in The New York Times, in which she shared her very private decision to have a preventive double mastectomy after testing positive for the BRCA1 gene mutation. “I hope that other women can benefit from my experience,” wrote Jolie. “Cancer is still a word that strikes fear into people’s hearts, producing a deep sense of powerlessness.” But for Jolie, and many others, getting genetic testing and taking action may offer control and comfort.